Ignite Creation Date:
2025-12-26 @ 10:18 PM
Ignite Modification Date:
2026-02-28 @ 7:02 AM
Study NCT ID:
NCT02002312
Status:
COMPLETED
Last Update Posted:
2015-08-13
First Post:
2013-11-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer
Sponsor:
Organization: